The emergence of the COVID-19
infectious disease pandemic has necessitated action to help ensure
the unaccompanied alien children and program staff health and
safety within the Unaccompanied Alien Children (UAC) Program. The
COVID-19 risk questionnaire asks participants whether or not they
display COVID-19 symptoms, whether or not they have had close
contact with individuals known to test positive for COVID-19, and
whether or not they have travel history to areas of sustained
transmission of COVID-19. The information collected by conducting
this survey at UAC programs will help ensure the health and safety
of children in our care and our program staff by helping to
identify and reduce potential exposure to COVID-19. Due to the time
sensitivity of collecting the information in the proposed COVID-19
risk questionnaire, we are requesting from OMB expedited review and
approval through special processing. A request for review under
normal procedures will be submitted within 180 days of the approval
for this request.
Due to the time
sensitivity of collecting the information in the proposed COVID-19
risk questionnaire, we are requesting from OMB expedited review and
approval through special processing. A request for review under
normal procedures will be submitted within 180 days of the approval
for this request.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.